Cas:355809-46-0 [6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol manufacturer & supplier

Chemical Name:[6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol

CAS.NO:355809-46-0

Synonyms:[6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol

Molecular Formula:C₁₄H₁₅NO₃

Molecular Weight:245.27400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:51.58000

Exact Mass:245.10500

LogP:2.25810

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like [6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol Use and application,[6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol technical grade,usp/ep/jp grade.

Related News: It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305. [6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol manufacturer From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances). [6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol supplier Like SARS, this latest outbreak is caused by a coronavirus, a family of viruses common to animals that range from the common cold, to more serious diseases, like Middle East respiratory syndrome (MERS). [6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. [6-(2,4-dimethoxyphenyl)pyridin-2-yl]methanol factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.